Anaphylaxis Management: EAACI Releases New Guidelines Anaphylaxis Management: EAACI Releases New Guidelines
The guidelines, an update from 2014, emphasize IM epinephrine as first-line treatment and call for simulation training for healthcare professionals.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - August 27, 2021 Category: Intensive Care Tags: Emergency Medicine News Source Type: news

New Grading System for Acute Allergic Reactions New Grading System for Acute Allergic Reactions
The new grading system will help clinicians and patients talk about anaphylactic and nonanaphylactic allergic reactions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 6, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

What You Don ’t Know About Food Allergies
Pollen-food reactions, adult onset symptoms and cross reactivity are just some of the surprising ways our bodies respond to food. (Source: NYT Health)
Source: NYT Health - July 19, 2021 Category: Consumer Health News Authors: Jane E. Brody Tags: Allergies Anaphylactic Shock Food Peanuts Seafood Pollen Sesame Seeds Children and Childhood Source Type: news

Anaphylaxis Caused by Artisanal Honey in a Child Anaphylaxis Caused by Artisanal Honey in a Child
This case of anaphylaxis in a 5-year-old boy highlights the potentially serious consequences of honey allergy, especially in patients sensitized to weed pollens.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 15, 2021 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Experts Advise on Rare Severe Allergic Reactions to COVID Vaccines Experts Advise on Rare Severe Allergic Reactions to COVID Vaccines
Anaphylactic reactions to SARS-CoV-2 mRNA vaccines may occur but are rare, according to an expert panel that has developed recommendations on diagnosis and management.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 6, 2021 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Hymenoptera venom immunotherapy: immune mechanisms of induced protection and tolerance - Dem šar Luzar A, Korošec P, Kosnik M, Zidarn M, Rijavec M.
Hymenoptera venom allergy is one of the most severe allergic diseases, with a considerable prevalence of anaphylactic reaction, making it potentially lethal. In this review, we provide an overview of the current knowledge and recent findings in understandi... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Government panel shares its findings on 31 vaccine-related adverse events
The report by the National Adverse Event Following Immunisation (AEFI) committee confirmed that a 68-year-old man died due to anaphylaxis, an allergic reaction, after receiving the jab on March 8. The vaccine received was Covishield. (Source: The Economic Times)
Source: The Economic Times - June 16, 2021 Category: Consumer Health News Source Type: news

Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced overall survival (OS) results from the Phase 3 MAIA (NCT02252172) study showing the addition of DARZALEX® (daratumumab) to lenalidomide and dexamethasone (D-Rd) resulted in a statistically significant survival benefit over lenalidomide and dexamethasone (Rd) alone in patients with newly diagnosed multiple myeloma (NDMM) who were ineligible for autologous stem cell transplant (ASCT) and were treated to progression.[1] These data were featured in the European Hematology Association (EHA) 2021 Virtual Press Briefin...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Mastocytosis and Hymenoptera Venom Allergy Profiled in the U.S.
Mastocytosis occurs more often among U.S. patients with hymenoptera venom anaphylaxis versus general population (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 3, 2021 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Allergy, Oncology, Journal, Source Type: news

Mastocytosis and Hymenoptera Venom Allergy Profiled in the U.S.
THURSDAY, June 3, 2021 -- The prevalence of hymenoptera venom anaphylaxis (HVA) in the United States is 0.167 percent, and mastocytosis is more common among those with HVA, according to a study recently published in the Journal of Allergy and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 3, 2021 Category: Pharmaceuticals Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Updated Data Demonstrate Significant Improvement in Hematologic Complete Response with DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, N.J., May 26, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the Phase 3 ANDROMEDA study, which evaluated DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare blood cell disorder associated with the deterioration of vital organs, most notably the heart, kidneys and liver.[1] Longer-term results from a median follow-up of 20.3 months showed rates of hematologic complete response (hemCR) remained significantly higher in patients treated with DARZALEX FASPRO®...
Source: Johnson and Johnson - May 26, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

What are Common Causes of Anaphylaxis?
Discussion Anaphylaxis is a potentially life-threatening hypersensitivity reaction of the body. Usually anaphylaxis is IgE mediated but complement-mediated immune complex reactions or IgG mediated reactions can cause anaphylaxis. Usually mucous membranes or skin are involved, but it is a systemic disease process with at least 2 systems involved (respiratory is second most common followed by gastrointestinal system). The epidemiology is difficult to discern but the estimated incidence is about 50-112 episodes per 100,000 person-years and estimated prevalence is 0.3-5.1%. There is data supporting an increased incidence. Over...
Source: PediatricEducation.org - May 17, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Covid vaccine: Anaphylaxis is a severe allergic reaction with these four symptoms to know
COVID vaccines side effects can be far more serious and possibly life threatening if suffering with allergies. There are four warning side effects prompting a case of anaphylaxis. (Source: Daily Express - Health)
Source: Daily Express - Health - May 16, 2021 Category: Consumer Health News Source Type: news

Main Causes of Food-Induced Anaphylaxis Identified Main Causes of Food-Induced Anaphylaxis Identified
Most triggers remain the same, but soybean may be less important.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 7, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Postmortem diagnostics of assumed suicidal food anaphylaxis in prison: a unique case of anaphylactic death due to peach ingestion - Tambuzzi S, Gentile G, Boracchi M, Di Candia D, Bianchi R, Zoja R.
Suicidal ingestion of food which the victim is aware they are allergic to is an exceptional occurrence in the forensic field. To the best of our knowledge, no cases of suicidal food anaphylaxis have been reported to date. Therefore we present the first cas... (Source: SafetyLit)
Source: SafetyLit - May 5, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Prevalence of mastocytosis and hymenoptera venom allergy in the United States - Schuler CF, Volertas S, Khokhar D, Yuce H, Chen L, Baser O, Montejo JM, Akin C.
BACKGROUND: Mastocytosis is a risk factor for hymenoptera venom anaphylaxis (HVA). Current guidelines recommend measuring tryptase in HVA patients and that those with mastocytosis pursue lifelong venom immunotherapy (VIT). Available data on HVA and mastocy... (Source: SafetyLit)
Source: SafetyLit - April 27, 2021 Category: International Medicine & Public Health Tags: Non-Human Animals and Insects Source Type: news

5 Takeaways From the New Food Allergy Law
Sesame becomes a “major allergen,” joining milk, eggs, fish, shellfish, tree nuts, peanuts, wheat and soybeans. (Source: NYT Health)
Source: NYT Health - April 26, 2021 Category: Consumer Health News Authors: Eric Athas Tags: Allergies Labeling and Labels (Product) Peanuts Anaphylactic Shock Food Content Type: Service Law and Legislation Sesame Seeds Food and Drug Administration Source Type: news

Use of the J & J Vaccine for COVID-19 Can Resume, Says CDC Review Panel
In a 10 to 4 vote, a committee of the U.S. Centers for Disease Control (CDC) on April 23 decided to lift the temporary hold on using the COVID-19 vaccine made by Johnson & Johnson/Janssen. The U.S. Food and Drug Administration (FDA) and CDC had temporarily halted vaccination with the J&J shot on April 13 after six reports of unusual blood clots in the brain occurred among nearly 7 million people vaccinated with the shot in the U.S. The panel of 15 independent experts was under some pressure to make a decision about the safety of the vaccine, which is the only single-shot vaccine for COVID-19 currently authorized in...
Source: TIME: Health - April 23, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Anaphylaxis Case After mRNA Vaccination Traced to Polyethylene Glycol Allergy Anaphylaxis Case After mRNA Vaccination Traced to Polyethylene Glycol Allergy
An undiagnosed polyethylene glycol allergy was at the root of at least one anaphylaxis case associated with an mRNA-based COVID-19 vaccine, a UK report suggests.Reuters Health Information (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - April 13, 2021 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications
●  Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatmentBasel, 13 April 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application for Xolair® (omalizumab) prefilled syringe for self-injection across all approved U.S. indications.1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic ...
Source: Roche Media News - April 13, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications
●  Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatmentBasel, 13 April 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application for Xolair® (omalizumab) prefilled syringe for self-injection across all approved U.S. indications.1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic ...
Source: Roche Investor Update - April 13, 2021 Category: Pharmaceuticals Source Type: news

New insights on cause of anaphylaxis following COVID-19 vaccination
(Wiley) On the first day of the UK campaign for COVID-19 vaccination, there were reports of two cases of anaphylaxis — a severe, potentially life-threatening allergic reaction — within minutes of administration of the Pfizer/BioNTech mRNA vaccine. Subsequently further cases of suspected anaphylaxis to the Pfizer vaccine were reported. A new report published in Clinical& Experimental Allergy reveals that an allergy to the ingredient polyethylene glycol (PEG) is a cause of anaphylaxis to the vaccine. However, this is in the context of millions of doses safely administered. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 7, 2021 Category: Infectious Diseases Source Type: news

Allergic Reactions, Anaphylaxis After Moderna COVID-19 Vaccine Allergic Reactions, Anaphylaxis After Moderna COVID-19 Vaccine
This report summarizes the clinical and epidemiologic characteristics of allergic reactions, including anaphylaxis and nonanaphylaxis reactions, after receipt of the Moderna COVID-19 vaccine.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 29, 2021 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Anaphylaxis After First Dose of Pfizer COVID-19 Vaccine Anaphylaxis After First Dose of Pfizer COVID-19 Vaccine
This report outlines their clinical and epidemiologic characteristics.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 15, 2021 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

European PRAC concludes safety signal of anaphylaxis with COVID-19 Vaccine AstraZeneca, European Medicines Agency
Following a review of the available data, the European PRAC has recommended an update to the product information to include anaphylaxis and hypersensitivity as side effects and to update the existing warning to reflect that cases of anaphylaxis have been reported. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 15, 2021 Category: Consumer Health News Source Type: news

Rates of Acute Allergic Reactions to COVID-19 Vaccines Extremely Low
THURSDAY, March 11, 2021 -- Severe reactions consistent with anaphylaxis have occurred among 2.47 per 10,000 health care workers receiving COVID-19 vaccinations, according to a research letter published online March 8 in the Journal of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 11, 2021 Category: Pharmaceuticals Source Type: news

Real world data reveal risks of allergic reactions after receiving COVID-19 mRNA vaccines
(Massachusetts General Hospital) Among 52,805 health care employees who received mRNA COVID-19 vaccines, 2% experienced allergic reactions, and anaphylaxis occurred at a rate of 2.47 per 10,000 individuals. All vaccine recipients who experienced anaphylaxis recovered without going into anaphylactic shock or requiring a breathing tube. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 9, 2021 Category: Infectious Diseases Source Type: news

Fake vegan meat is dangerous to peanut allergy sufferers: Pea protein could cause fatal anaphylaxis
(Natural News) Vegan meats could bring adverse health effects, most especially to those who are allergic to pea protein. Elana Levine, an allergy specialist in Ontario, Canada, witnessed first-hand the effects of the protein extracts from yellow peas that are used to emulate the texture and taste of animal meat in vegan meat products. It was when... (Source: NaturalNews.com)
Source: NaturalNews.com - March 6, 2021 Category: Consumer Health News Source Type: news

First anaphylaxis case from a deodorant spray including lysozyme chloride - Muramatsu R, Saga M, Muramatsu K.
[The publisher has not provided an abstract for this article.] Language: en... (Source: SafetyLit)
Source: SafetyLit - March 4, 2021 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Covid vaccine side effects: Anaphylaxis is a rare but life-threatening reaction
CORONAVIRUS vaccines are hastening the end of the pandemic, with hospital ICU rates plummeting. Most people getting the Pfizer/BioNTech vaccine will experience mild side effects at most. In very rare instances, anaphylaxis may occur - what is it? (Source: Daily Express - Health)
Source: Daily Express - Health - March 2, 2021 Category: Consumer Health News Source Type: news

Covid vaccine side effects: Anaphylaxis is a rare but severe allergic reaction
CORONAVIRUS vaccines are hastening the end of the pandemic, with hospital ICU rates plummeting. Most people getting the Pfizer/BioNTech vaccine will experience mild side effects at most. In very rare instances, anaphylaxis may occur - what is it? (Source: Daily Express - Health)
Source: Daily Express - Health - March 2, 2021 Category: Consumer Health News Source Type: news

1998 to 2018 Saw Jump in Admissions for Food-Induced Anaphylaxis
THURSDAY, Feb. 18, 2021 -- From 1998 to 2018, there was an increase in hospital admissions for food-induced anaphylaxis in the United Kingdom, according to a study published online Feb. 17 in The BMJ. Alessia Baseggio Conrado, Ph.D., from Imperial... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 18, 2021 Category: Pharmaceuticals Source Type: news

Hospitalizations for Food Anaphylaxis Triple, but Deaths Down Hospitalizations for Food Anaphylaxis Triple, but Deaths Down
Cow's milk is the leading cause of fatal anaphylaxis among children, new data show.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - February 18, 2021 Category: Emergency Medicine Tags: Allergy & Clinical Immunology News Source Type: news

No provision of insurance for recipients of COVID-19 vaccine: Ashwini Choubey, MoS for Health
Measures have been put in place like availability of anaphylaxis kits at each vaccination site, immediate referral to AEFI management centre and observation of vaccine recipients for 30 minutes at session site for any adverse events so as to ensure timely corrective measure, Choubey said in a written reply. (Source: The Economic Times)
Source: The Economic Times - February 9, 2021 Category: Consumer Health News Source Type: news

Pfizer withdraws vaccine plea as panel seeks India trial data
The panel observed that incidents of serious adverse effects such as palsy and anaphylaxis and the causality of the events with the vaccine were being investigated in some of the countries where these jabs have been administered. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 5, 2021 Category: Pharmaceuticals Source Type: news

COVID Vaccine Anaphylaxis: Who Is at Risk? COVID Vaccine Anaphylaxis: Who Is at Risk?
What's the most likely cause of the reported anaphylactic reactions to the COVID vaccines, and how can physicians keep patients safe?Medscape Allergy & Immunology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 29, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology Viewpoint Source Type: news

COVID-19 vaccination programme, RCGP (updated 28th January 2021)
The latest updates on the COVID-19 vaccine, including: COVID-19 Vaccination FAQs SARS-CoV-2 Vaccination #RCGPLive: COVID-19 vaccination in general practice Clinician FAQs and guidance on COVID-19 vaccine for patients receiving Systemic Anti-Cancer Therapy (SACT) Managing anaphylaxis: guidance for GPs delivering the COVID-19 vaccine (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 29, 2021 Category: Consumer Health News Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe CO...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe COVID-19, wit...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021
This report describes cases of anaphylaxis after administration of first doses of the Moderna COVID-19 vaccine during December 21, 2020-January 10, 2021. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 28, 2021 Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report Vaccination Vaccine Adverse Event Reporting System (VAERS) Vaccines COVID-19 Coronavirus Disease 2019 Source Type: news

The First 15 Minutes: Anaphylaxis After COVID Vaccination The First 15 Minutes: Anaphylaxis After COVID Vaccination
Most postvaccination symptoms are expected and not serious, although clinicians should be ready to manage the rare case of anaphylaxis.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2021 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

The First 30 Minutes: Anaphylaxis After COVID Vaccination The First 30 Minutes: Anaphylaxis After COVID Vaccination
Most postvaccination symptoms are expected and not serious, although clinicians should be ready to manage the rare case of anaphylaxis.Medscape Internal Medicine (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - January 27, 2021 Category: Emergency Medicine Tags: Internal Medicine Commentary Source Type: news

Moderna's and Pfizer's vaccines share the same problem: They're unsafe for people with allergies
(Natural News) A physician at the Boston Medical Center (BMC) suffered an allergic reaction after receiving the much-talked about Moderna vaccine. The incident, which occurred on Dec. 24, involved Dr. Hossein Sadrzadeh, a geriatric oncologist with a severe allergy to shellfish. Sadrzadeh reported symptoms of anaphylaxis similar to what he experiences with shellfish almost immediately after receiving the Moderna... (Source: NaturalNews.com)
Source: NaturalNews.com - January 26, 2021 Category: Consumer Health News Source Type: news

2.5 Anaphylaxis Cases Reported Per Million COVID-19 Moderna Vaccine Shots
MONDAY, Jan. 25, 2021 -- The rate of anaphylaxis is 2.5 cases per million Moderna COVID-19 vaccine doses administered as of Jan. 10, 2021, according to research published in the Jan. 22 issue of the U.S. Centers for Disease Control and Prevention... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 25, 2021 Category: Pharmaceuticals Source Type: news

Moderna Covid-19 Vaccine: Here Is The Risk Of Severe Allergic Reactions
A new CDC reported listed the rate of anaphylaxis after the Moderna Covid-19 mRNA as slightly lower than that of the Pfizer/BioNTech vaccine. But is this difference real? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 23, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

Covid US: 10 out of 4m who got Moderna vaccine suffered anaphylaxis
Just one person who went into anaphylactic shock - a life-threatening response in which a person's airways can become too narrow for them to breathe - had no history of allergies, CDC reports. (Source: the Mail online | Health)
Source: the Mail online | Health - January 23, 2021 Category: Consumer Health News Source Type: news

10 out of 4 million Americans to get Moderna's vaccine suffered anaphylaxis
Just one person who went into anaphylactic shock - a life-threatening response in which a person's airways can become too narrow for them to breathe - had no history of allergies, CDC reports. (Source: the Mail online | Health)
Source: the Mail online | Health - January 22, 2021 Category: Consumer Health News Source Type: news

Allergic reactions including anaphylaxis after receipt of 1st dose of Pfizer-BioNTech COVID-19 Vaccine
(JAMA Network) This JAMA Insights review provides clinical details of anaphylactic reactions reported to and verified by the Centers for Disease Control and Prevention in the first week of use of the Pfizer-BioNTech COVID-19 vaccine in the United States. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 21, 2021 Category: International Medicine & Public Health Source Type: news

How Safe Are Covid-19 Coronavirus Vaccines? Here ’s The Allergic Reaction Risk
A CDC report indicated that there were 21 cases of anaphylaxis (severe allergic reactions) out of 1,893,360 people who had received first doses of the Pfizer-BioNTech Covid-19 vaccine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 16, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news